192 results
8-K
EX-99.1
INVA
Innoviva Inc
13 May 24
Corporate Presentation May 2024
9:27am
– a serious complication, particularly for ICU patients Positioned to avoid common stewardship and access concerns Other branded antibiotics push … continues to rise Unique patient populations Other populations where stockable oral therapies would be preferred due to uneven access to healthcare
DEFA14A
INVA
Innoviva Inc
29 Apr 24
Additional proxy soliciting materials
5:30pm
to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important … make this request on or before June 5, 2024.
Your control number
Have the 12 digit control number located in the box above available when you access
8-K
EX-10.1
yqho5 3f5
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
edo kdi00f4uy2w
24 May 23
Corporate Presentation May 2023
5:18pm
DEFA14A
y9c223n7p
17 May 23
Additional proxy soliciting materials
5:18pm
8-K
EX-99.1
p18 ycomm224n3jaf5
14 Sep 22
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
z56sv5 vsypjk3h
23 Aug 22
Other Events
4:08pm
SC TO-T
EX-99
rtnhz68hdmn su8
25 Jul 22
Third party tender offer statement
8:34am
8-K
EX-10.1
s3g7ct1ln go7hdy5e
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm